12
Aug
2010
Posted in I - Series B, Q - 3Q10, R - NORTH EAST, X - Cardiology, X - G-Protein, X - Pain, XX - PA
Trevena (Berwyn, PA) a clinical-stage small molecule company focused on G-protein coupled receptor targeting for heart failure and pain, closed a $35M Series B funding from existing investors. Participants include Polaris Venture Partners, New Enterprise Associates, Alta Partners, Healthcare Ventures and Yasuda Enterprise Development Company.
02
Mar
2009
Posted in I - Series A, Q - 1Q09, R - INTERNATIONAL, X - G-Protein, X - Parkinson's
Heptares Therapeutics (United Kingdom) a discovery-stage company focused on small-molecule drugs targeting G-protein-coupled receptors whose lead indication is Parkinson’s, closed a $29.9M Series A financing. Participants include Clarus Ventures, MVM Life Science Partners and Novartis Ventures Option Fund.
04
Jan
2009
Posted in I - Series A, Q - 4Q08, R - INTERNATIONAL, X - G-Protein, X - Therapeutic Platform
Domain Therapeutics (France) and early-stage company focused on the identification of allosteric modulators of G Protein-Coupled Receptors closed a $2.9M Series A financing. Participants include Alsace Inter Regio Fonds d’Investissement, Alsace Création, Sam Eletr and Bernard Gilly. AGF Private Equity, Auriga Partners, Edmond de Rothschild Investment Partners and Sofinnova Partners.
03
Dec
2008